12:10 PM EST - Nirvana Life Sciences Inc : Announces that it has entered a supply agreement with Symeres B.V. for the supply of compounds to support the Company's ongoing research program. Under this agreement Symeres will supply Psilocybin and other materials to be used in trials and ongoing research. Nirvana Life Sciences Inc
shares C.NIRV are trading up $0.06 at $0.56.
